Bigul

Advertisement Of Notice Of Twenty Third Annual General Meeting, E-Voting And Book Closure Information

Advertisement of Notice of twenty Third Annual General Meeting, e-voting and Book Closure information
24-07-2018
Bigul

Board Meeting Scheduled To Be Held On August 13, 2018.

We hereby inform that the meeting of the Board of Directors of the Company will be held on Monday, August 13, 2018 to consider apart from other agenda items to approve the unaudited financial results for the quarter ended on June 30, 2018. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from August...
23-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from the USFDA for Acetylcysteine Injection
21-07-2018
Bigul

Zydus Cadila gets USFDA nod for high blood pressure, heart failure treatment drug

Zydus Cadila has received final approval from the US health regulator to market Spironolactone tablets, used to treat high blood pressure and heart
20-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from the USFDA for Spironolactone Tablets USP
20-07-2018
Bigul

Zydus Cadila gets USFDA nod for arthritis drug

Zydus Cadila has received final approval from the US health regulator for Piroxicam capsules, used for the treatment of osteoarthritis and rheumatoid
19-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from the USFDA for Piroxicam Capsules USP
19-07-2018
Bigul

Zydus Cadila gets USFDA nod to market 4 generic products

Pharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America. The comp
18-07-2018
Bigul

Cut Off Date Intimation

Cut Off Date Intimation
18-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives four consecutive ANDA approvals from the USFDA
18-07-2018
Next Page
Close

Let's Open Free Demat Account